Year: 2025
Type: article
Abstract: Intravenous fluid therapy has evolved significantly from its origins in the cholera epidemics of the 19th century to its modern application in sepsis management.This evolution has been shaped by pivotal medical discoveries and landmark clinical trials, including the introduction of Early Goal-Directed Therapy (EGDT) for septic shock. 1 However, we now recognize that fluid therapy is not without risks-overzealous administration can lead to pulmonary edema, abdominal compartment syndrome, organ dysfunction, and increased mortality.2
Source: Onco Critical Care.
Author: Saurabh Kumar Das, MD
Institution: Max Super Speciality Hospital
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W4410418441